The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InAmid shifting investment priorities within the healthcare landscape, BMO Capital Markets has initiated coverage of the MedTech sector, highlighting opportunities arising from recent sector weakness. According to reports, the firm identified Intuitive Surgical (ISRG), Globus Medical (GMED), and Teleflex (TFX) as its top high-conviction picks. The brokerage believes the MedTech space is currently undervalued, presenting a significant buying window for investors looking to capitalize on beaten-down valuations.
This bullish stance comes as the medical device industry navigates headwinds from the rise of GLP-1 medications, though analysts point toward continued growth in robotic surgery adoption. Compared to peers like Stryker and Medtronic, which have shown mixed quarterly results, Intuitive Surgical maintains a dominant market position. Per market data, ISRG shares stood at $415.1 at the close of July 8, 2026, reflecting resilience despite broader market volatility.
Investors should monitor key technical levels for ISRG, which traded between a low of $414.59 and a high of $428.47 as of the July 8, 2026 close. Looking ahead, macro catalysts such as the upcoming ISM Services PMI data in the United States could influence broader sentiment toward growth-oriented MedTech stocks, potentially impacting the capital flows into BMO's newly designated top picks.